Trials / Completed
CompletedNCT02107599
The Feasibility of Florbetapir Quantitation in Europe
A Study to Evaluate the Improvement in Reader Accuracy When Using a Read Method That Incorporates Commercially Available Quantitative Analysis Software as an Adjunct to the Clinical Visual Interpretation of Amyvid Brain Scans
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 96 (actual)
- Sponsor
- Avid Radiopharmaceuticals · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This study will evaluate whether the addition of quantitation as an adjunct to visual interpretations significantly improves the accuracy of Amyvid scan interpretation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Florbetapir (18F) | No Florbetapir (18F) will be administered in this study. |
Timeline
- Start date
- 2014-03-01
- Primary completion
- 2014-05-01
- Completion
- 2014-05-01
- First posted
- 2014-04-08
- Last updated
- 2015-07-09
- Results posted
- 2015-07-09
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT02107599. Inclusion in this directory is not an endorsement.